Prevalence of associated psychosomatic symptoms in patients of irritable bowel syndrome

Authors

  • Anwar Habib Department of Medicine, HIMSR, Jamia Hamdard, New Delhi, India
  • Razi Ahmad Department of Pharmacology, HIMSR, Jamia Hamdard, New Delhi, India
  • Sana Rehman Department of Pharmacology, HIMSR, Jamia Hamdard, New Delhi, India

DOI:

https://doi.org/10.18203/2349-3933.ijam20184767

Keywords:

Low socio-economic strata, Irritable bowel syndrome, Psychosomatic disorder

Abstract

Background: Irritable bowel syndrome (IBS) is a functional disorder of gastrointestinal tract with unclear aetiology and no reliable biomarkers like other chronic and functional disorders. Majority of the patients of IBS suffer from various forms of psychosomatic disorders as comorbidity that further exaggerate the complexity of diagnosis and management of IBS. The aim of the present study was to find the prevalence of commonly associated psychosomatic symptoms associated with IBS in the patients of lower socioeconomic strata.

Methods: This is a prospective observational study carried out over a period of 10years from November-2007 till October-2017, in HAHC hospital attached to Hamdard Institute of Medical Sciences and Research. A structured questionnaire comprising of a total of 36 closed ended questions was designed. Eleven questions were about the demographic characteristics and twenty-five were pertaining to IBS symptoms according to Manning and Rome III criteria with some necessary modifications. Various psychosomatic illnesses were recorded separately after ruling out the organic cause with appropriate investigations.

Results: In the present study out of 4000 patients with IBS symptoms, 70.8% were having some form of psychosomatic symptoms, Patients with psychosomatic disorders were significantly more often young in age and females (53.28%), showing highest number of patients belonging to the age group 26-35years (51.44%). 34% patient had two or more psychosomatic illnesses. Headache (62.26%) and insomnia (63.03%) were the commonest followed by chest pain (36.54%). Chest pain (77.68%), headache (62.26%) and insomnia (56.07%) was more common in male whereas palpitation (60.58%) and breathlessness (57.68%) was more common in female.

Conclusions: There is significantly high prevalence of psychosomatic illness in the patients of IBS in the low socio-economic strata. The young patients (productive age group) are more affected which may be responsible for further deteriorating their social and economic condition.

References

Welgan P, Meshkinpour H, Ma L. Role of anger in antral motor activity in irritable bowel syndrome. Digestive Dis Sci. 2000 Feb 1;45(2):248-51.

Riedl A, Schmidtmann M, Stengel A, Goebel M, Wisser AS, Klapp BF, et al. Somatic comorbidities of irritable bowel syndrome: a systematic analysis. J Psychosomatic Res. 2008 Jun 1;64(6):573-82.

Sperber AD, Atzmon Y, Neumann L, Weisberg I, Shalit Y, Abu-Shakrah M, et al. Fibromyalgia in the irritable bowel syndrome: studies of prevalence and clinical implications. Am J Gastroenterol. 1999 Dec;94(12):3541.

Smith MD, Russell A, Hodges PW. How common is back pain in women with gastrointestinal problems?. Clin J Pain. 2008 Mar 1;24(3):199-203.

Guo YJ, Ho CH, Chen SC, Yang SS, Chiu HM, Huang KH. Lower urinary tract symptoms in women with irritable bowel syndrome. Int J Urol. 2010 Feb;17(2):175-81.

Elsenbruch S, Harnish MJ, Orr WC. Subjective and objective sleep quality in irritable bowel syndrome. Am J Gastroenterol. 1999 Sep;94(9):2447.

Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterol. 2002 Dec 1;123(6):2108-31.

Cohen H, Jotkowitz A, Buskila D, Pelles-Avraham S, Kaplan Z, Neumann L, et al. Post-traumatic stress disorder and other co-morbidities in a sample population of patients with irritable bowel syndrome. European J Internal Med. 2006 Dec 1;17(8):567-71.

Koloski NA, Talley NJ, Boyce PM. The impact of functional gastrointestinal disorders on quality of life. Am J Gastroenterol. 2000 Jan;95(1):67.

Miller V, Hopkins L, Whorwell PJ. Suicidal ideation in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2004 Dec 1;2(12):1064-8.

Koloski NA, Talley NJ, Boyce PM. Epidemiology and health care seeking in the functional GI disorders: a population-based study. Am J Gastroenterol. 2002 Sep 1;97(9):2290-9.

Locke GR, Weaver AL, Melton III LJ, Talley NJ. Psychosocial factors are linked to functional gastrointestinal disorders: a population based nested case-control study. Am J Gastroenterol. 2004 Feb;99(2):350.

Lydiard RB, Falsetti SA. Experience with anxiety and depression treatment studies: implications for designing irritable bowel syndrome clinical trials. Am J Med. 1999 Nov 8;107(5):65-73.

Tollefson GD, Tollefson SL, Pederson M, Luxenberg M, Dunsmore G. Comorbid irritable bowel syndrome in patients with generalized anxiety and major depression. Ann Clin Psychiatry. 1991 Jan 1;3(3):215-20.

Heaton KW, O'Donnell LJ, Braddon FE, Mountford RA, Hughes AO, Cripps PJ. Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters. Gastroenterol. 1992 Jun 1;102(6):1962-7.

Masand PS, Kaplan DS, Gupta S, Bhandary AN, Nasra GS, Kline MD, Margo KL. Major depression and irritable bowel syndrome: is there a relationship?. J Clin Psychiatry. 1995 Aug;56:363-7.

Kumar BR, Dudala SR, Rao AR. Kuppuswamy’s socio-economic status scale-a revision of economic parameter for 2012. Int J Res Dev Health. 2013 Jan;1(1):2-4.

Posserud I, Agerforz P, Ekman R, Björnsson ES, Abrahamsson H, Simrén M. Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress. Gut. 2004 Aug 1;53(8):1102-8.

Longstreth GF. Irritable bowel syndrome. In: Manu P, eds. Functional Somatic Syndrome. Cambridge: University Press; 1998:55-73.

Lydiard RB. Irritable bowel syndrome, anxiety, and depression: what are the links?. J Clin Psychiatry. 2001.

Farthing MJ. Fortnightly Review: Irritable bowel, irritable body, or irritable brain?. BMJ. 1995 Jan 21;310(6973):171-5.

Walker EA, Gelfand AN, Gelfand MD, Katon WJ. Psychiatric diagnoses, sexual and physical victimization, and disability in patients with irritable bowel syndrome or inflammatory bowel disease. Psychological Med. 1995 Nov;25(6):1259-67.

Kurina LM, Goldacre MJ, Yeates D, Gill LE. Depression and anxiety in people with inflammatory bowel disease. J Epidemiol Community Health. 2001 Oct 1;55(10):716-20.

Karling P, Danielsson Å, Adolfsson R, Norrback KF. No difference in symptoms of irritable bowel syndrome between healthy subjects and patients with recurrent depression in remission. Neurogastroenterol Motility. 2007 Nov;19(11):896-904.

Pata C, Erdal ME, Derici E, Yazar A, Kanık A, Ulu O. Serotonin transporter gene polymorphism in irritable bowel syndrome. Am J Gastroenterol. 2002 Jul;97(7):1780.

Camilleri M, Atanasova E, Carlson PJ, Ahmad U, Kim HJ, Viramontes BE, et al. Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome. Gastroenterol. 2002 Aug 1;123(2):425-32.

Kilpatrick LA, Labus JS, Coveleskie K, Hammer C, Rappold G, Tillisch K, et al. The HTR3A polymorphism c.-42C> T is associated with amygdala responsiveness in patients with irritable bowel syndrome. Gastroenterol. 2011 Jun 1;140(7):1943-51.

Mayer EA, Naliboff BD, Chang L, Coutinho SV. V. Stress and irritable bowel syndrome. Am J Physiol Gastrointestinal Liver Physiol. 2001 Apr 1;280(4):G519-24.

Drossman DA. The role of psychosocial factors in gastrointestinal illness. Scand J Gastroenterol Suppl. 1996;221:1-4..

Whitehead WE, Crowell MD, Robinson JC, Heller BR, Schuster MM. Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut. 1992 Jun 1;33(6):825-30.

Rehman S, Habib A, Ahmad R, Baluja Z. Assessment of IBS symptoms among patients of lower socio-economic strata attending medicine OPD in a tertiary care hospital in South Delhi. Int J Advances Medi. 2017 Jul 20;4(4):1117-22.

Vanuytsel T, van Wanrooy S, Vanheel H, Vanormelingen C, Verschueren S, Houben E, et al. Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism. Gut. 2014 Aug 1;63(8):1293-9.

Iorio N, Makipour K, Palit A, Friedenberg FK. Post-traumatic stress disorder is associated with irritable bowel syndrome in African Am. J Neurogastroenterol and motility. 2014 Oct;20(4):523.

Downloads

Published

2018-11-22

Issue

Section

Original Research Articles